Mre11 Dysfunction Is Associated With Triple-Negative Breast Cancer and Confers Sensitivity to DNA Damaging Therapy
G.P. Gupta(University of North Carolina at Chapel Hill), John H.J. Petrini(Memorial Sloan Kettering Cancer Center), Simon N. Powell(Memorial Sloan Kettering Cancer Center), Edi Brogi(Memorial Sloan Kettering Cancer Center), Wei Feng(University of North Carolina at Chapel Hill), Cheng Fan(University of North Carolina at Chapel Hill), C. Perou(University of North Carolina at Chapel Hill), Yuetao Wen(Memorial Sloan Kettering Cancer Center), M. Akram(Memorial Sloan Kettering Cancer Center), Alice Y. Ho(Houston Methodist)
International Journal of Radiation Oncology*Biology*Physics
October 1, 2016
Cited by 1
Related Papers
Clinical-grade computational pathology using weakly supervised deep learning on whole slide images
|Nature Medicine|2019|2.6k
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
|Breast Cancer Research|2010|2.1k
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k